Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition.

Sengal, Asmerom T; Bonazzi, Vanessa; Smith, Deborah; Moiola, Cristian P; Lourie, Rohan; Rogers, Rebecca; Colas, Eva; Gil-Moreno, Antonio; Frentzas, Sophia; Chetty, Naven; Perrin, Lewis; Pollock, Pamela M

Sengal, Asmerom T; Bonazzi, Vanessa; Smith, Deborah; Moiola, Cristian P; Lourie, Rohan; Rogers, Rebecca; Colas, Eva; Gil-Moreno, Antonio; Frentzas, Sophia; Chetty, Naven; Perrin, Lewis; Pollock, Pamela M.

Afiliación

Sengal AT; Endometrial Cancer Laboratory, School of Biomedical Sciences, Faculty of Health, the Queensland University of Technology located at the Translational Research Institute (TRI), PA Hospital Campus, 37 Kent St Woolloongabba, Brisbane, 4102, QLD, Australia. asmerom.sengal@qut.edu.au.
Bonazzi V; Endometrial Cancer Laboratory, School of Biomedical Sciences, Faculty of Health, the Queensland University of Technology located at the Translational Research Institute (TRI), PA Hospital Campus, 37 Kent St Woolloongabba, Brisbane, 4102, QLD, Australia.
Smith D; Frazer Institute, The University of Queensland, Brisbane, QLD, 4102, Australia.
Moiola CP; Mater Pathology, Mater Health, Brisbane, QLD, Australia.
Lourie R; Biomedical Research Group in Gynaecology, Vall Hebron Institute of Research (VHIR), CIBERONC, 08035, Barcelona, Spain.
Rogers R; Mater Pathology, Mater Health, Brisbane, QLD, Australia.
Colas E; Mater Pathology, Mater Health, Brisbane, QLD, Australia.
Gil-Moreno A; Biomedical Research Group in Gynaecology, Vall Hebron Institute of Research (VHIR), CIBERONC, 08035, Barcelona, Spain.
Frentzas S; Biomedical Research Group in Gynaecology, Vall Hebron Institute of Research (VHIR), CIBERONC, 08035, Barcelona, Spain.
Chetty N; Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia.
Perrin L; Faculty of Medicine, Nursing and Health Sciences and School of Clinical Sciences, Monash University, Melbourne, VIC, Australia.
Pollock PM; Department of Gynaecologic Oncology, Mater Cancer Centre, Mater Health Services, Brisbane, QLD, Australia.

NPJ Precis Oncol ; 7(1): 127, 2023 Dec 08.

Article en En | MEDLINE | ID: mdl-38062117

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2023 Tipo del documento: Article